These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23229679)

  • 41. Acquired T-Cell Immunodeficiency in Thymoma Patients.
    Christopoulos P; Fisch P
    Crit Rev Immunol; 2016; 36(4):315-327. PubMed ID: 28322136
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response to Comment on "A Novel Thymoma-Associated Immunodeficiency with Increased Naive T Cells and Reduced CD247 Expression".
    Fisch P; Christopoulos P; Marx A; Schamel WW
    J Immunol; 2015 Oct; 195(8):3505-6. PubMed ID: 26432898
    [No Abstract]   [Full Text] [Related]  

  • 43. Comment on "A Novel Thymoma-Associated Immunodeficiency with Increased Naive T Cells and Reduced CD247 Expression".
    Welsh JS; Howard SP
    J Immunol; 2015 Oct; 195(8):3505. PubMed ID: 26432897
    [No Abstract]   [Full Text] [Related]  

  • 44. Thymoma with immunodeficiency with multiple recurrent oral herpetic infections.
    Aydintug YS; Bayar GR; Ozkan A; Gunhan O; Musabak U
    J Dent Sci; 2016 Mar; 11(1):103-106. PubMed ID: 30894954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of suppressor cell activity appearing in cocultures of two individuals with immunodeficiency with thymoma.
    Litwin SD
    Scand J Immunol; 1980; 11(1):15-22. PubMed ID: 9537024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Gaps in the regulatory T cell shield generate immunopathologies].
    Bacher P
    Z Rheumatol; 2018 Dec; 77(10):923-927. PubMed ID: 30302535
    [No Abstract]   [Full Text] [Related]  

  • 47. A nosology of immune diseases from deep immunophenotyping.
    McDermott MF
    Nat Rev Rheumatol; 2024 May; 20(5):256-257. PubMed ID: 38467781
    [No Abstract]   [Full Text] [Related]  

  • 48. The clinical spectrum of thymoma-associated immunodeficiency: Good syndrome and beyond.
    Wang C; Shi Y; Lim XR; Walter JE
    Eur J Intern Med; 2024 Apr; ():. PubMed ID: 38616482
    [No Abstract]   [Full Text] [Related]  

  • 49. Strabismus Associated With the Good Syndrome (Immunodeficiency and Thymoma).
    Gupta A; Pakravan M; Charoenkijkajorn C; Lee AG
    J Neuroophthalmol; 2023 May; ():. PubMed ID: 37163355
    [No Abstract]   [Full Text] [Related]  

  • 50. Modeling primary immune regulatory disorders: Ferrari or Yugo?
    Jordan MB
    Immunol Cell Biol; 2017 Oct; 95(9):739-740. PubMed ID: 28925382
    [No Abstract]   [Full Text] [Related]  

  • 51. [A rare case of aberrant thymoma].
    Rill A
    Med Pregl; 1970; 23(3):135-6. PubMed ID: 5204789
    [No Abstract]   [Full Text] [Related]  

  • 52. Sunitinib in the Treatment of Thymoma and Associated Autoimmune Neutropenia.
    Becker H; Auman K; Claus R; von Bubnoff N; Sachs UJ; Waller CF
    JCO Precis Oncol; 2017 Nov; 1():1-7. PubMed ID: 35172505
    [No Abstract]   [Full Text] [Related]  

  • 53. Type B3 thymoma complicated with
    Jiang J; Dai J; Hu X; Yao X; Mo W; Wang H
    Exp Ther Med; 2024 Apr; 27(4):153. PubMed ID: 38476920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunological signature of patients with thymic epithelial tumors and Good syndrome.
    Malfitano AM; D'Esposito V; De Placido P; Tortora M; Ottaviano M; Pietroluongo E; Morra R; Mucci B; Napolitano F; Montella L; Giuliano M; De Placido S; Terracciano D; Palmieri G; Formisano P
    Front Immunol; 2022; 13():908453. PubMed ID: 36059463
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic Model of Eleven Genes Based on the Immune Microenvironment in Patients With Thymoma.
    Yang Y; Xie L; Li C; Liu L; Ye X; Han J
    Front Genet; 2022; 13():668696. PubMed ID: 35222524
    [No Abstract]   [Full Text] [Related]  

  • 56. Thymoma appearing 9 years after the resection of squamous cell carcinoma of the lip: A case report of triple primary tumors and literature review.
    Maruyama N; Sasaki T; Arasaki A; Matsuzaki A; Nakasone T; Teruya T; Matayoshi A; Maruyama T; Karube K; Fujita J; Yoshimi N; Kuniyoshi Y; Nishihara K
    Oncol Lett; 2019 Sep; 18(3):2777-2788. PubMed ID: 31452756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.
    Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ
    Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aberrant Peripheral Immune Function in a Good Syndrome Patient.
    Chen X; Zhang JX; Shang WW; Xie WP; Jin SX; Wang F
    J Immunol Res; 2018; 2018():6212410. PubMed ID: 29850635
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation in West Nile Virus Structural Protein prM during Human Infection.
    Lustig Y; Lanciotti RS; Hindiyeh M; Keller N; Milo R; Mayan S; Mendelson E
    Emerg Infect Dis; 2016 Sep; 22(9):1647-9. PubMed ID: 27322782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Associated immunological disorders and cellular immune dysfunction in thymoma: a study of 87 cases from Thailand.
    Thongprayoon C; Tantrachoti P; Phatharacharukul P; Buranapraditkun S; Klaewsongkram J
    Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):85-93. PubMed ID: 23229679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.